Search | Page 20 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Evaluation of RUX and AZA Combination as a Therapy For Patients With Myelofibrosis And Myelodysplastic Syndrome/ Myeloproliferative Neoplasm

    ... Associated Drug(s):  Azacitidine Phase:  Phase 2 ... 1, 2 and 3. Other Names: Jakafi INCB018424 INC424 Drug: Azacitidine (AZA) Four weeks (28 days) on therapy is considered one standard ...

    Clinical Trial last updated 04/28/2016 - 1:56pm.

  2. A Phase II Study of 5-Azacitidine and Sargramostim as Maintenance Treatment After Definitive Therapy for Poor-risk AML or MDS

    ... Associated Drug(s):  Azacitidine Phase:  Phase 2 ... Intervention:  Drug: 5-azacitidine and sargramostim 5-azacitidine will be administered days 1-5 of a ...

    Clinical Trial last updated 05/03/2016 - 10:38am.

  3. Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

    ... Alemtuzumab Azacitidine Fludarabine Phase:  ...

    Clinical Trial last updated 05/02/2016 - 11:10am.

  4. Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS (UPCI 13-165)

    ... Associated Drug(s):  Azacitidine Phase:  Phase 2 ...

    Clinical Trial last updated 04/29/2016 - 10:26am.

  5. A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

    ... Associated Drug(s):  Azacitidine Phase:  Phase 2 ...

    Clinical Trial last updated 04/27/2016 - 9:37am.

  6. MDS - Treatment (OLD)

    ... to specifically treat MDS in the U.S. These include azacitidine (Vidaza®) and decitabine (Dacogen®), both considered ...

    Topic section last updated 03/10/2016 - 11:01pm.

  7. Clinical Trials Report for April 2015

    ... to an Erythropoiesis Stimulating Agent (ESA) and/or Azacitidine (AZA) followed by a dose expansion part with an additional 30 ... NCT02363491 Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) The goal of this ...

    Page last updated 03/30/2015 - 11:40am.

  8. Clinical Trials Report for November 2015

    ... Efficacy and Safety Study of CC-486 (ORAL AZACITIDINE) in Subjects With Myelodysplastic Syndromes The primary ... study is to Evaluate the efficacy and safety of CC-486 (ORAL AZACITIDINE) in subjects with myelodysplastic syndromes. This study is ...

    Page last updated 10/30/2015 - 8:46am.

  9. Clinical Trials Report for October 2015

    ... Efficacy and Safety Study of CC-486 (ORAL AZACITIDINE) in Subjects With Myelodysplastic Syndromes The primary ... study is to Evaluate the efficacy and safety of CC-486 (ORAL AZACITIDINE) in subjects with myelodysplastic syndromes. This study is ...

    Page last updated 09/30/2015 - 10:53am.

  10. MDS Drug Information

    ... T risenox azacitidine V idaza ...

    Page last updated 01/20/2015 - 4:46pm.